• LAST PRICE
    3.5000
  • TODAY'S CHANGE (%)
    Trending Down-0.3500 (-9.0909%)
  • Bid / Lots
    3.4000/ 4
  • Ask / Lots
    3.5100/ 5
  • Open / Previous Close
    3.8000 / 3.8500
  • Day Range
    Low 3.2950
    High 3.8100
  • 52 Week Range
    Low 1.8550
    High 16.3000
  • Volume
    410,533
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 3.85
TimeVolumeOMER
09:32 ET73673.8001
09:34 ET89553.8
09:39 ET37483.7
09:43 ET2003.78
09:48 ET36023.7
09:50 ET14003.66
09:52 ET92003.65
09:54 ET2003.63
09:56 ET12003.63
09:57 ET22003.605
10:01 ET1003.605
10:03 ET15883.58
10:06 ET15003.58
10:08 ET15003.6
10:10 ET16003.59
10:14 ET4003.58
10:15 ET9533.5737
10:17 ET50573.58
10:19 ET23093.57
10:21 ET4003.55
10:30 ET1513.55
10:32 ET17993.5101
10:33 ET14903.52
10:35 ET20003.52
10:42 ET4003.51
10:44 ET5003.5
10:46 ET12903.51
10:48 ET1003.48
10:50 ET97093.49
10:51 ET27323.4599
10:53 ET83633.46
10:55 ET111203.4712
11:00 ET1003.48
11:02 ET2533.47
11:04 ET2003.4588
11:06 ET14303.43
11:08 ET53043.45
11:09 ET6003.45
11:11 ET37753.45
11:13 ET28673.46
11:18 ET32883.44
11:20 ET35273.435
11:22 ET38553.435
11:24 ET17003.4314
11:26 ET25563.42
11:27 ET4003.4177
11:29 ET134363.36
11:31 ET2203.36
11:33 ET1003.3567
11:36 ET31243.32
11:38 ET117413.335
11:40 ET64083.33
11:42 ET45023.39
11:44 ET8233.41
11:45 ET2703.4164
11:47 ET211873.37
11:49 ET1003.38
11:51 ET49013.38
11:54 ET32013.41
11:56 ET5003.4176
11:58 ET7083.38
12:00 ET2003.37
12:02 ET5003.37
12:03 ET6003.38
12:05 ET5003.35
12:07 ET11683.34
12:09 ET15003.33
12:14 ET2003.34
12:16 ET3003.34
12:18 ET9663.3395
12:21 ET76513.355
12:23 ET1783.3699
12:25 ET1003.355
12:30 ET7003.3494
12:32 ET8563.345
12:34 ET26283.35
12:36 ET6003.36
12:38 ET101743.36
12:39 ET10003.3601
12:41 ET2903.365
12:43 ET4123.37
12:45 ET3003.365
12:48 ET83003.34
12:50 ET1003.34
12:54 ET21503.36
12:59 ET1003.38
01:03 ET15603.39
01:06 ET1003.39
01:12 ET25003.4285
01:15 ET2213.4139
01:17 ET16723.44
01:19 ET1003.44
01:21 ET1003.44
01:28 ET3003.45
01:30 ET4003.45
01:32 ET5503.456
01:33 ET19003.442
01:35 ET1003.44
01:37 ET1003.45
01:39 ET1003.45
01:42 ET5883.4415
01:44 ET2003.45
01:46 ET1003.45
01:48 ET3003.46
01:50 ET4003.47
01:51 ET2003.47
01:53 ET2003.46
02:00 ET4003.46
02:02 ET10003.4615
02:08 ET2003.47
02:09 ET9903.485
02:11 ET4003.49
02:13 ET26003.4899
02:15 ET4003.49
02:18 ET2163.49
02:22 ET33733.52
02:31 ET4003.53
02:36 ET1003.53
02:42 ET3003.53
02:44 ET1003.54
02:45 ET1003.54
02:47 ET4003.545
02:49 ET30023.52
02:51 ET3883.52
02:54 ET10003.54
02:56 ET4003.51
02:58 ET1003.51
03:02 ET15033.52
03:03 ET18863.51
03:05 ET5003.5
03:07 ET5003.515
03:09 ET67113.53
03:12 ET10503.55
03:14 ET4003.54
03:18 ET34043.53
03:20 ET150673.525
03:21 ET3003.51
03:23 ET1003.49
03:25 ET1003.48
03:27 ET28003.455
03:30 ET15513.46
03:34 ET2003.48
03:36 ET6113.4599
03:38 ET9003.4325
03:39 ET30013.4401
03:41 ET22203.4399
03:43 ET62463.43
03:45 ET6213.4399
03:48 ET40153.43
03:50 ET11403.43
03:52 ET2773.43
03:56 ET9373.435
03:57 ET28263.435
03:59 ET117433.5
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesOMER
Omeros Corp
219.6M
-1.2x
---
United StatesLIAN
LianBio
221.0M
-2.1x
---
United StatesANTX
AN2 Therapeutics Inc
217.3M
0.0x
---
United StatesCMPX
Compass Therapeutics Inc.
226.9M
-5.6x
---
United StatesSTSA
Satsuma Pharmaceuticals Inc
231.2M
-3.8x
---
United StatesACIU
AC Immune SA
200.5M
-2.5x
---
As of 2022-09-24

Company Information

Omeros Corporation is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic diseases, including complement-mediated diseases and cancers related to dysfunction of the immune system, as well as addictive and compulsive disorders. Its lead lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject of a biologics license application for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA). Narsoplimab is also in multiple late-stage clinical development programs focused on other complement-mediated disorders, including IgA nephropathy, atypical hemolytic uremic syndrome, and COVID-19. OMS906, its inhibitor of MASP-3, an activator of the alternative pathway of complement, is initiating a Phase I b clinical program in paroxysmal nocturnal hemoglobinuria (PNH).

Contact Information

Headquarters
201 Elliott Avenue WestSEATTLE, WA, United States 98119
Phone
206-676-5000
Fax
206-676-5005

Executives

Chairman of the Board, President, Chief Executive Officer
Gregory Demopulos
Vice President - Finance, Chief Accounting Officer, Treasurer
Michael Jacobsen
Vice President - Science, Chief Scientific Officer
George Gaitanaris
Vice President, General Counsel, Secretary
Peter Cancelmo
Vice President - Human Resources
Peter Williams

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$219.6M
Revenue (TTM)
$-21.1M
Shares Outstanding
62.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.19
EPS
$-3.00
Book Value
$0.38
P/E Ratio
-1.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.